Ran Poliakine’s New Innovation Center is Now Open for Applications
Feb 8, 2018 – Ran Poliakine of Nveh Ilan hase just announced the launch of a brand-new innovation center that intends to focus on early-stage ventures in
Prof. David Naor’s Drug Could Treat Alzheimer’s, MS, Crohn’s and More
February 11,2018 Prof. David Naor, from the Lautenberg Center for General and Tumor Immunology at the Hebrew University-Hadassah Medical School, Jerusalem, believes that all these diseases, which
BioCanCell Announces Updated Results from the Phase II Clinical Trial of BC-819 and BCG in Patients With Bladder Cancer
Nov. 15, 2017 (GLOBE NEWSWIRE) — BioCancell Therapeutics (TASE:BICL), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to treat
Oramed Receives Regulatory Approval to Conduct Clinical Study for Treatment of NASH With its Oral Insulin Capsule
Nov. 14, 2017 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced
World first MRI for the NeoNatal ICU has been successfully working at Jerusalem’s Shaare Zedek Medical Center for the last three months
January 10, 2018 Aspect Imaging ‘s Embrace® dedicated Neonatal Magnetic Resonance Imaging (MRI) system has now received both the EC mark and FDA clearance. The
First patients Enrolled in Immuron’s IMM-529 Clinical Study at Hadassah Medical Center in Israel
January 31, 2018 – Immuron (ASX:IMC) (NASDQ:IMRN), an Australian microbiome biopharmaceutical company focused on developing and commercializing oral immune-therapeutics for the treatment of gut mediated diseases,
Shaare Zedek Medical Center Signs MoU with Indian Central Council for Research in Homeopathy
January 18, 2018 The Centre for Integrative Complementary Medicine of Shaare Zedek Medical Center in Jerusalem signed a pact with the Central Council for Research in Homoeopathy, Ministry of AYUSH. The pact is
Intec Pharma Names R. Michael Gendreau, M.D., Ph.D. as CMO
January 31, 2018 – Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: NTEC), a clinical stage biopharmaceutical company focused on developing pharmaceutical therapies based on its proprietary Accordion Pill™ platform
The MUSE(TM) Procedure for GERD Treatment Performed First Time in Israel at Shaare-Zedek Medical Center
Dec 27, 2017 – Dr. Wengrower, Head, Therapeutic Endoscopy Unit, and his colleagues Dr. Paz and Dr. Livovsky at the Digestive Diseases Institute, Shaare-Zedek Medical
